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Abstract. Whole genome amplification methods are a recently developed tool for amplifying DNA from limited
template. We report its application in trypanosome infections, characterized by low parasitemias. Multiple displacement
amplification (MDA) amplifies DNA with a simple in vitro step and was evaluated on mouse blood samples on FTA
filter cards with known numbers of Trypanosoma brucei parasites. The data showed a 20-fold increase in the number of
PCRs possible per sample, using primers diagnostic for the multicopy ribosomal ITS region or 177-bp repeats, and a
20-fold increase in sensitivity over nested PCR against a single-copy microsatellite. Using MDA for microsatellite
genotyping caused allele dropout at low DNA concentrations, which was overcome by pooling multiple MDA reactions.
The validity of using MDA was established with samples from Human African Trypanosomiasis patients. The use of
MDA allows maximal use of finite DNA samples and may prove a valuable tool in studies where multiple reactions are
necessary, such as population genetic analyses.
INTRODUCTION
African trypanosomes cause a disease syndrome across a
wide geographic area of sub-Saharan Africa. In domestic live-
stock, disease is caused by Trypanosoma congolense, Trypa-
nosoma vivax, and, to a lesser extent, Trypanosoma brucei,
whereas in humans, disease is caused by T. brucei gambiense
and T. brucei rhodesiense. Diagnosis is routinely by micro-
scopic techniques, which are relatively insensitive, or by se-
rology in the case of humans, which may not necessarily in-
dicate current infection, and is reliant upon the broad speci-
ficity of the antigen used as the basis for the assay.1 The
causative agent of 97% of human cases is T. b. gambiense,2
infections of which are characterized by chronic infections
with very low parasitemias that are therefore difficult to de-
tect by microscopy.3–5 Prevalence as measured by traditional
microscopic diagnosis has been shown to be significantly un-
derestimated in both animal and human infections, as shown
by comparative polymerase chain reaction (PCR) surveys,6
and by an epidemiology and modeling study.7 Current meth-
ods for analysis of T. b. gambiense are unsatisfactory as they
depend either on inoculation and amplification in rodents or
on growth in vitro.8,9 In both of these cases, the methodology
is difficult to use in field settings and is associated with the
inevitable selection of strains and potential distortion of our
understanding of the genetic structure of parasite popula-
tions.9 Thus a method that enables direct analysis of field
samples, even those occurring at a low level in the host, would
allow a range of studies that include parasite and host popu-
lation genetics.
DNA samples, such as those collected in the field or hos-
pital situations, are often one-off finite resources, and the
amount of DNA available is usually the limiting factor in the
extent and sensitivity of analyses that can be performed. With
available resources, such as sequenced genomes, there is an
increase in numbers of markers, such as micro- and minisat-
ellites and single-nucleotide polymorphisms (SNPs), that can
be analyzed. This in turn leads to much improved power in
studies that, for example, involve genotyping and genetic as-
sociation. These analyses will only prove possible if the
bottleneck of restricted starting template is overcome. In ad-
dition, replica tests are often required, and retrospective stud-
ies are commonly undertaken, so maximizing the number of
tests that can be performed on a single sample is a critical
issue to address.
PCR has allowed detection of low concentrations of DNA,
and the threshold of detection is further increased when
nested PCR is utilized. However, even with these techniques,
if the target DNA concentration of a sample is low, for ex-
ample in the case of a hemoparasite blood sample with a low
circulating parasite burden, the number of reactions possible
is limited. Recently, whole genome amplification (WGA)
methods have been developed for increasing the amount of
template available.10 Multiple displacement amplification
(MDA)11 employs the bacteriophage 29 DNA polymerase,
which efficiently replicates large stretches (> 10 kb) of
double-stranded DNA utilizing random hexamer primers and
strand displacement.10 The fact that the reaction takes place
at 30°C means that the genome(s) present in a sample can
effectively be replicated using a simple in vitro reaction. This
method has been demonstrated to be efficient at amplifying
some 93% of loci 250-fold from a single human cell.12 Al-
though the 29 DNA polymerase has a very low error rate,
estimated as 1 in 106 bp,13 and replicates large stretches of
DNA, there is a potential drawback. Failure to amplify both
alleles at heterozygous loci (“allele dropout”) from single hu-
man cells has been detected at up to 31% of heterozygous
loci.14 If higher quantities of template DNA are used, how-
ever, the successful amplification of both alleles at heterozy-
gous loci increases to 97% when 10 or 100 ng of human DNA
is used.15 Because quantitative or population genetic studies
require identification of heterozygous loci, this is an impor-
tant issue to address when considering the application of this
technique.
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Infected blood samples on FTA filters (Whatman Bio-
Sciences Ltd., Brentford, UK) are commonly used as a re-
source in many disciplines for transporting DNA samples
from the field, and so we have used such samples as a source
for this study to optimize the analysis of T. brucei infections.
These filters are easy to use because they automatically lyse
cells, inactivate viruses, bind the target DNA, and provide a
safe and stable matrix for transport. The filters represent a
finite sample resource when used with standard PCR ap-
proaches. The first approaches taken were to use mouse
blood with known dilutions of trypanosomes to define the
sensitivity of PCR and to estimate the benefits of utilizing
MDA in terms of multiplying the number of reactions that
can be carried out on any one sample. The analysis was un-
dertaken with oligonucleotide primers that were trypano-
some-specific,16,17 T. brucei species-specific,18 and finally with
primers that targeted a single-copy heterozygous microsatel-
lite locus.19 This allowed analysis of the sensitivity with both
multiple- or single-copy target sequences and of the fidelity of
amplification of both alleles for a single-copy heterozygous
locus. We then analyzed a set of field samples from human
African trypanosomiasis (HAT) patients in the Democratic
Republic of Congo (DRC) to test both the findings from the
laboratory-based experiments and the potential benefits of
using MDA on field samples.
MATERIALS AND METHODS
FTA filter preparation. To examine thresholds of detec-
tion, TREU 927 (genome reference strain) trypanosomes
were grown in an ICR mouse (Harlan, Bicester, UK) from a
cryopreserved stabilate, and the blood was collected at the
first peak of parasitemia (≈ 1 × 108 parasites per mL) by
cardiac puncture. The parasites were counted in triplicate us-
ing an improved Neubauer hemocytometer, and dilutions
were made in fresh, unparasitized mouse blood with 1 × 101,
1 × 102, 1 × 103, 1 × 104, and 1 × 105 parasites per mL. Two
hundred microliters of each dilution was spotted onto an FTA
filter (Whatman) and allowed to air-dry in the dark overnight.
Two hundred microliters of uninfected mouse blood was also
spotted onto a filter for use as a parasite-negative control.
Filters were routinely stored at 4°C in the dark, with silica
desiccant. The maintenance and care of experimental animals
complied with the appropriate legislation; the UK Animals
(Scientific Procedures) Act, 1986; and with the national and
University of Glasgow maintenance and care guidelines.
The field samples were blood samples collected by
venepuncture from consenting patients, with ≈ 200 L spotted
onto an FTA filter and allowed to air-dry. The samples were
collected in Maluku, 80 km north of Kinshasa, DRC, in 2003.
The parasitemia of the samples was estimated at the point of
collection by the capillary tube centrifugation (CTC) tech-
nique,20 and all samples used in this study were positive by
microscopy. Ethical permission for this study has been
granted by OMS/IRD and the University of Glasgow.
For use in PCR, discs were punched out of the FTA blood
spot using a clean 2-mm diameter Harris micropunch (What-
man), and the discs were then washed 3 times with 200 L of
FTA purification reagent (Whatman) and twice with 200 L
of 1 mM TE (10 mM Tris, 1 mM EDTA) buffer, pH 8.0, with
incubations for 5 minutes at each wash as per the manufac-
turer’s instructions. The washes were necessary to reduce the
many potential PCR inhibitors present in blood.21 The
washed discs were air-dried for an hour and were then used as
substrate in MDA reactions or PCRs.
MDA reactions. MDA reactions were carried out directly
on washed FTA punched discs. The MDA protocol followed
was as described by the manufacturer, in a final volume of 20
L (GenomiPhi DNA Amplification kit; Amersham Bio-
sciences, Piscataway, NJ). When MDA reactions were
pooled, 3 independent reactions were carried out at each try-
panosome concentration, the reactions at each concentration
were pooled and mixed, and 1 L of the pooled reactions
used as template for PCR. MDA products were routinely
stored at −20°C.
PCR primers and conditions. PCR amplification was car-
ried out directly on washed FTA discs using the following
conditions: PCR buffer (45 mM Tris-HCl, pH 8.8, 11 mM
(NH4)2SO4, 4.5 mM MgCl2, 6.7 mM 2-mercaptoethanol, 4.4
M EDTA, 113 g per mL BSA, 1 mM of each 4 deoxyri-
bonucleotide triphosphates), 1 M of each oligonucleotide
primer, and 1 unit of Taq polymerase (ABgene, Epsom, UK)
per 20-L reaction or 2.5 U per 50-L reaction. Two single-
copy heterozygous microsatellite markers (PLC and JS2)
were amplified in this study, using the PCR primers and con-
ditions described previously,19 and new primer pairs were
designed to amplify the outer fragment for the nested PCRs
(sequences from 5 to 3): JS2-C, AGTAATGGGAAT-
GAGCGTCACCAG, and JS2-D, GATCTTCGCTTACA-
CAAGCGGTACl; PLC-G2, TTAAGTGGACGACGAC-
GAAATAACAACA, and PLC-H4, TTCAAACACCGTC-
CCCCTCAATAAT. PCR amplification of 2 different
multicopy genes was also carried out: one set directed against
the ribosomal DNA internal transcribed spacer (ITS),16,17
and the other targeting the 177-base pair (bp) repeats found
in the trypanosome genome,18 using the conditions described
above. PCR amplification was carried out using 1 disc (PCR
volume, 20 L), and 5 discs per blood dilution (PCR volume,
50 L; for nested PCR, 50 L in the first-round amplification
and 20 L in the second-round amplification). For PCR am-
plification of MDA products, 1 L of amplification product
was used as template, in a volume of 20 L. In the case of the
nested PCRs, 1 L of a 1/100 dilution of first-round product
was used as template in the second-round PCR, except for the
nested ITS primers, where 1 L from the first-round PCR was
carried over.17 Negative controls were included for both PCR
on discs and MDA reactions, using as template an FTA disc
spotted with uninfected mouse blood and also a reaction with
no template. PCR products were resolved by electrophoresis
on a 3% Nusieve GTG agarose gel (Cambrex, East Ruther-
ford, NJ), and were stained with 0.2 g/mL ethidium bromide
to allow visualization under UV light. All reactions were car-
ried out at least 5 times, to ensure reproducibility of results.
GeneScan analysis. When analyzing the field samples, 1
primer of the second-round nested PCRs targeting the single-
copy heterozygous microsatellite (PLC) included a 5 FAM
modification. This enabled accurate sizing and sensitive de-
tection of alleles by the separation of products using a capil-
lary-based sequencer (ABI 3100 Genetic Analyser; Applied
Biosystems, Foster City, CA). DNA fragment size was deter-
mined relative to a set of ROX-labeled size standards (GS500
markers; Applied Biosystems) using GeneScan software,
which allowed resolution to 1 bp.
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RESULTS
The first approach was to directly compare standard and
nested PCR amplification, using either reactions carried out
directly on FTA filters or on the MDA product from FTA
filters (Table 1). Sensitivity was measured in 2 ways: “abso-
lute sensitivity,” referring to the trypanosome concentration
of the infected blood spotted onto the FTA filter, and “effec-
tive sensitivity,” which takes into account the dilution factor
involved inherent in the MDA method. Effective sensitivity is
a measurement of the number of trypanosomes per PCR re-
action, more accurately reflecting the multiplication of tem-
plate by MDA. The threshold of reproducible detection in
terms of effective sensitivity for both alleles of the single-copy
microsatellite marker PLC by single-round PCR was 10 try-
panosomes per reaction. Using nested PCR, the sensitivity
was increased 10-fold to 1 trypanosome per reaction. The
sensitivity when using the product of an MDA reaction from
a single FTA disc as template was at the level of 0.05 trypano-
some per reaction, a 20-fold increase in sensitivity compared
with nested PCR. However, when 5 discs were used as a
template for MDA, allele dropout was observed at 1 trypano-
some per reaction (Table 1). In the cases of allele dropout, the
allele that failed to amplify was not consistently the same
allele, suggesting no homologue bias in the MDA reaction.
This problem was overcome by the pooling of 3 independent
MDA reactions, with sensitivity observed down to 0.05 try-
panosome per reaction, and amplification of both alleles for
reactions from both 1 and 5 discs. Although the absolute
sensitivity does not increase between nested PCR on FTA
disc and nested PCR using MDA as template, both having a
threshold of 1 × 103 trypanosomes per mL, the increase in
effective sensitivity for MDA represents the increase in num-
ber of reactions that can be carried out at the same threshold
of absolute sensitivity. All negative controls, using either un-
infected mouse blood or no DNA as template, did not result
in amplification of product for any reaction. Overall, for
single-copy sequences, MDA increases effective sensitivity
20-fold over nested PCR and 100-fold over single-round PCR.
The second approach examined whether sensitivity could
be increased by amplification of multicopy sequences, using
primers specific to the ITS and 177-bp repeats; results are
shown in Table 2. Using the 177-bp repeat as a target, ampli-
fications by PCR18 were able to detect the presence of trypa-
nosomes down to the level of 0.025–0.1 trypanosome per re-
action (corresponding to 100 trypanosomes per mL absolute
sensitivity) both with 1 washed disc or with the MDA prod-
ucts (1 or 5 discs) as template. This may be the limit of de-
tection, as determined by the probability of a single trypano-
some being present in the original blood volume captured in
1 or 5 discs of an FTA filter. The single-round ITS PCR
amplifications16 were less sensitive, detecting only to the level
of 2.5–10 trypanosomes per reaction, for 1 washed disc or
MDA products from 1 or 5 discs. Nested primers to the ITS
sequence17 were also used in an attempt to overcome this lack
of sensitivity. The nested ITS primers improved the level of
sensitivity 10-fold over the non-nested ITS primers, to 0.25–1
trypanosome per reaction, still representing a sensitivity 10-
fold less than that observed for the 177-bp repeats. PCR am-
plification was 5-fold less sensitive with all sets of primers
when carried out on 5 washed discs than was PCR amplifica-
tion using 1 washed disc; it was also less sensitive than using
MDA product from 1 or 5 discs. The decreased sensitivity
with 5 discs is very likely due to the presence of increased
amounts of PCR inhibitors in the reaction. These results in-
dicate that use of WGA products in PCRs does not greatly
increase sensitivity when multicopy genes are used as the tar-
get for PCR, in contrast to the improved sensitivity using
single-copy markers. PCRs using the product from MDA re-
actions from 5 discs are equally as sensitive as nested PCR
directly on 1 disc.
The use of WGA to effectively increase the available ma-
terial for genotyping was examined using blood samples from
HAT patients from the DRC spotted onto FTA filters. An
estimate of the parasitemia was undertaken at the point of
collection by the capillary tube centrifugation (CTC) tech-
nique, which gave an approximate measure of trypanosome
concentrations, ranging from 251 to 1,000 trypanosomes per
mL (Table 3). Discs from 11 samples spotted on FTA cards
were used as the templates for MDA reactions. Nested PCRs
using primers for the microsatellites JS2 and PLC were then
carried out using 5 discs and on 3 pooled, independent MDA
reactions using 5 discs each. GeneScan analysis of the PCR
products allowed sizing of individual alleles and also detec-
TABLE 1
Sensitivity analysis for a single-copy gene; numbers of trypanosomes per reaction, and trypanosome concentration in initial blood at which the
microsatellite marker PLC was reproducibly detected by PCR amplification are shown
Effective
sensitivity
Absolute
sensitivity
Single-round
PCR
Nested
PCR
Absolute
sensitivity
MDA and nested PCR
1 disc 5 discs pooled
500 1 × 105 + + ND ND ND ND
100 1 × 105 + + ND ND ND ND
50 1 × 104 + + ND ND ND ND
10 1 × 104 + + ND ND ND ND
5 1 × 103 − + 1 × 105 + + +
1 1 × 103 − + 1 × 105 + +* +
0.5 1 × 102 − − 1 × 104 + +* +
0.1 1 × 102 − − 1 × 104 + +* +
0.05 1 × 101 − − 1 × 103 +* +* +
0.01 1 × 101 − − 1 × 103 − − −
0 0 − − 0 − − −
“1 disc” or “5 discs” indicates the number of washed FTA discs used as the initial template; “+,” reproducible successful amplification and detection of both alleles; ”+*,” concentrations at
which allele dropout was observed; “−,” no product observed; ND, not determined. Effective sensitivity is the calculated number of trypanosomes present in the individual PCR. Absolute
sensitivity is the initial concentration of trypanosomes per mL of blood spotted onto the FTA card. There are two different values of effective sensitivity at the same absolute sensitivity value,
due to the use of 1 or 5 FTA discs, or 1 L (1 disc) or 0.4 L (5 discs) or 2 L (pooled) of MDA product, as PCR template.
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tion of low levels of product. Products were amplified from all
samples with both sets of primers revealing 2 alleles at the
PLC locus and 3 alleles at the JS2 locus (see Table 3). The
fidelity of the MDA reaction in terms of consistency of de-
tection of both alleles of heterozygous samples was examined
(Table 3). When products from single MDA reactions were
used, 1 sample out of 11 was homozygous for JS2, and 4 were
homozygous in the case of PLC (Table 3, bold). However,
when the reactions were repeated using 3 pooled MDA prod-
ucts, only 1 sample gave a homozygous genotype (MAL122
for PLC). Thus, 4 of the 5 homozygous results detected using
single MDA reactions were pseudo-homozygous, and only by
pooling MDA reactions could they be scored correctly. These
data highlight the problem of allele dropout when using
MDA and the necessity for repeated analysis or the use of
pooled MDA reactions to ensure accuracy of results with this
technique, particularly in instances when detection of het-
erozygosity is an important feature.
DISCUSSION
This study examined the potential use of MDA, the most
robust of the currently available WGA methods in terms of
unbiased genome amplification,22 in optimizing the analysis
of finite T. brucei DNA samples in the form of infected blood
spotted onto FTA filters. Analysis by PCR amplification of
single- or multicopy genes confirmed that the multicopy 177-
bp repeat target was the most sensitive method for detecting
the presence of trypanosomes, some 10-fold more sensitive
than the ribosomal internal transcribed spacer target DNA.
The 177-bp satellite repeats are found in large arrays, mainly
in the mini- and intermediate chromosomes of T. brucei,23
and so represent a battery of at least tens of thousands of
target sequences in the genome of each individual parasite.
The ITS sequences on the other hand, are fewer in number, at
≈ 20–40 copies per cell,24 and this difference in copy number
is likely to be the basis behind the difference in sensitivity. In
addition, the relatively low sensitivity of the ITS PCRs, which
has been noted previously,16 could be due to the fact that the
oligonucleotide primers are degenerate, as they are designed
to amplify across trypanosome species and so may not be
completely homologous to the target sequence. The lack of
sensitivity, even after MDA, may limit the use of the ITS
primers for field diagnosis of samples with low parasitemia.
The ITS primers were designed to generate bands of diagnos-
tically different size for each trypanosome species, allowing
the detection of multiple species in a single PCR. However,
the ITS PCRs are demonstrably less sensitive than the 177-bp
PCRs, although the 177-bp PCRs require an individual reac-
tion per trypanosome species. Use of MDA removes any re-
striction upon number of reactions per sample and allows the
use of multiple reactions using the very sensitive species-
specific 177-bp PCR.
The use of MDA can increase the possible number of re-
actions 20-fold and improves the effective sensitivity of de-
tection of single-copy genes. Nested PCR amplification of the
single-copy heterozygous microsatellite was 5-fold more sen-
sitive than single-round PCR amplification of the same target.
When MDA products were used in nested PCR, there was a
20-fold increase in effective sensitivity over direct nested
PCR on washed discs for the amplification of the single-copy
microsatellite. The issue of detection of single-copy genes is
important for two reasons. Firstly, the detection of human
infective trypanosomes relies upon amplification of single-
copy genes (SRA for T. b. rhodesiense25 and TgsGP for
T. b. gambiense26), and both targets have been used to iden-
tify human-infective trypanosomes from field samples on
FTA filters and to analyze the epidemiology of the disease.27
Secondly, single-copy target sequences—such as micro-
satellites, minisatellites, and SNPs—are the most widely used
loci for population genetic analyses.28 The use of field
samples that can be stably stored on FTA filters is a poten-
tially invaluable tool for population genetics, in terms of ac-
curately defining the parasite population. This is particularly
TABLE 3
Detection of heterozygosity of microsatellite markers JS2 and PLC
by PCR, from either single or 3 pooled MDA reactions on 5 FTA
discs of HAT cases from the DRC*
Marker
Sample
JS2 PLC
CTC countSingle Pooled Single Pooled
MAL100 1 2 1 2 2 2 1 2 251
MAL200 1 2 1 2 1 2 1 2 251
MAL300 1 2 1 2 1 2 1 2 251
MAL400 1 2 1 2 1 2 1 2 1000
MAL500 1 2 1 2 1 2 1 2 251
MAL600 1 2 1 2 1 2 1 2 1000
MAL800 1 2 1 2 1 2 1 2 251
MAL900 1 2 1 2 2 2 1 2 251
MAL10a 2 2 1 2 2 2 1 2 251
MAL111 1 4 1 4 1 2 1 2 251
MAL122 1 2 1 2 1 1 1 1 501
* Heterozygosity was analyzed both by visualisation of PCR product on ethidium bro-
mide-stained agarose gel, and by separation of FAM-labeled products on an ABI300 se-
quencer. Individual alleles were identified by size in bp by GENESCAN software and
allocated an identifying number. The numbers in the table indicate the alleles identified in
each case. Homozygous samples are highlighted in bold text. CTC count indicates the esti-
mation of trypanosome numbers (trypanosomes per mL) by the CTC technique.
TABLE 2
Sensitivity analysis for multicopy target sequences; the lowest concentrations of trypanosome at which multicopy targets, 177-bp repeats (177),
and internal transcribed spacer region (ITS) of ribosomal DNA were reproducibly detected by PCR amplification are shown*
Primer
PCR
(1 disc)
PCR
(5 discs)
MDA
(1 disc)
MDA
(5 discs)
AS ES AS ES AS ES AS ES
177 1 × 102 0.1 1 × 102 0.5 1 × 103 0.05 1 × 102 0.025
ITS 1 × 104 10 1 × 104 50 1 × 105 5 1 × 104 2.5
ITS nested 1 × 103 1 1 × 103 5 1 × 104 0.5 1 × 103 0.25
* Absolute sensitivity (AS) equates to the number trypanosomes per mL of blood spotted onto the FTA filter, and effective sensitivity (ES) is the number of trypanosomes calculated per
individual PCR. PCR, PCRs carried out on the specified number of washed discs; MDA, multiple displacement amplification reactions carried out on the specified number of washed discs; and
PCR undertaken using MDA product as template.
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useful as it requires no amplification of the trypanosomes in
culture or rodents. Current methods for the isolation of the
trypanosomes in a sample all potentially lead to selection of
particular genotypes. This problem seems to be particularly
noteworthy in the case of T. b. gambiense, where it has been
demonstrated that different genotypes can be isolated from
the same sample depending on whether a kit for in vitro iso-
lation (KIVI) or rodent inoculation methods were used.9 In-
deed, it has been suggested that the narrow range of geno-
types that will grow using the KIVI isolation method may be
a significant reason9 for the conclusion that T. b. gambiense
populations show low genetic variability and are clonal.29,30
Therefore, use of FTA filters will be important in terms of
determining the extent of genetic exchange and rigorously
examining the population structure of the African trypano-
somes.
The availability of polymorphic markers (microsatellite,
minisatellite, and SNPs) for both host and parasite is increas-
ing as a result of genome sequence resources, so the need to
be able to undertake multiple genotype analyses on a single
small sample will increase for association studies between
pathogen and host genotypes and disease. Use of MDA as a
tool to amplify the genomes present in a sample is potentially
extremely useful in this area, as the available template can be
amplified 20-fold, allowing multiple analyses to be under-
taken from a single sample. An important feature of this
study, which is relevant to other pathogens, is that even in the
presence of much greater quantities of host DNA, there is
effective amplification of low levels of the parasite genome.
When the increased sensitivity provided by MDA is com-
bined with the increased number of reactions, the benefits in
terms of increased information per sample are substantial. In
terms of laboratory research as well as detailed retrospective
studies, MDA may well prove invaluable. Although this study
has focused on trypanosomes, obviously the application of
this technique to any pathogen samples will have considerable
value.
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